0.00Open0.10Pre Close0 Volume0 Open Interest7.00Strike Price0.00Turnover4775.00%IV0.62%PremiumOct 18, 2024Expiry Date0.06Intrinsic Value100Multiplier-2DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type0.6871Delta2.4042Gamma70.57Leverage Ratio-382.9791Theta0.0000Rho48.49Eff Leverage0.0000Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet